Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention study.

[1]  B. Fagerberg,et al.  A randomized study of quality of life during multiple risk factor intervention in treated hypertensive men at high cardiovascular risk , 1995, Journal of hypertension.

[2]  HOMAS,et al.  The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .

[3]  L Wilhelmsen,et al.  Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden. , 1987, JAMA.

[4]  I. Hjermann,et al.  EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE , 1981 .

[5]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[6]  J Ménard,et al.  The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. , 1993, Blood pressure.

[7]  L. Wilhelmsen,et al.  Organization and efficacy of an out-patient hypertension clinic. , 2009, Acta medica Scandinavica.

[8]  N. Santanello,et al.  Cholesterol reduction yields clinical benefit. A new look at old data. , 1995, Circulation.

[9]  Scandinavian Simvastatin Survival Study Group.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[10]  M. Kornitzer,et al.  BELGIAN HEART DISEASE PREVENTION PROJECT: INCIDENCE AND MORTALITY RESULTS , 1983, The Lancet.

[11]  T. Hedner,et al.  Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden. , 1994, Journal of human hypertension.

[12]  V. Salomaa,et al.  Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. , 1991, JAMA.

[13]  H. Tunstall-Pedoe,et al.  Belgian Heart Disease Prevention Project: Incidence and mortality results , 1983 .

[14]  B. Fagerberg,et al.  Multifactorial treatment of hypertensive men at high cardiovascular risk and low‐density lipoprotein cholesterol affinity to human arterial proteoglycans , 1996, European journal of clinical investigation.

[15]  L. Ramsay,et al.  Dietary reduction of serum cholesterol concentration: time to think again. , 1991, BMJ.

[16]  A. Keys.  CORONARY HEART DISEASE IN SEVEN COUNTRIES , 1971, The Medical journal of Australia.

[17]  K. Borner,et al.  Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA-II) , 1977 .

[18]  M. Kornitzer,et al.  EUROPEAN COLLABORATIVE TRIAL OF MULTIFACTORIAL PREVENTION OF CORONARY HEART DISEASE: FINAL REPORT ON THE 6-YEAR RESULTS , 1986, The Lancet.

[19]  H. Tunstall-Pedoe,et al.  Comparison of tests used to distinguish smokers from nonsmokers. , 1987, American journal of public health.

[20]  B. Fagerberg,et al.  The efficacy of multiple risk factor intervention in treated hypertensive men during long‐term follow up , 1994, Journal of internal medicine.

[21]  Daniel Steinberg,et al.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.

[22]  J. Tuomilehto,et al.  Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. , 1988, JAMA.

[23]  O. Samuelsson.  Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care. , 1985, Acta medica Scandinavica. Supplementum.

[24]  L. Wilhelmsen,et al.  Multivariate Analysis of Risk Factors for Coronary Heart Disease , 1973, Circulation.